Posted by: Anonymous
on January 30, 2008 08:44 PM
Quote from the article:
Bostick agreed, saying, "The patent issue covers a specific implementation of anti-virus scanning. It's also a U.S. patent, which means that it's only going to cover intellectual property violations in the U.S. And frankly, as we sit here now, we're not aware of any other companies that are using ClamAV in the U.S. This is just not going to have a negative impact on open source." However, later, in responses to reworded questions about possible vulnerabilities, Bostick said, "That's always a possibility. I can only speak about this patent."
I wonder what anti-virus solution WatchGuard has been using since 2004?